Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Biomay is one of the manufacturers supplying BioNTech with the DNA template for the in-vitro transcription of their mRNA active ingredient. The manufacturing agreement was initiated during the clinical development phase of the Comirnaty vaccine in Q1/2020.
Lead Product(s): Tozinameran
Therapeutic Area: Infections and Infectious Diseases Product Name: Comirnaty
Highest Development Status: ApprovedProduct Type: Vaccine
Partner/Sponsor/Collaborator: BioNTech
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership May 17, 2021